GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Other Long-Term Liabilities

Psyence Biomedical (Psyence Biomedical) Other Long-Term Liabilities : $0.00 Mil (As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Other Long-Term Liabilities?

Psyence Biomedical's other long-term liabilities for the quarter that ended in Mar. 2023 was $0.00 Mil.


Psyence Biomedical Other Long-Term Liabilities Historical Data

The historical data trend for Psyence Biomedical's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Other Long-Term Liabilities Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
Other Long-Term Liabilities
- - -

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
Other Long-Term Liabilities - - -

Psyence Biomedical Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


Psyence Biomedical Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Biomedical (Psyence Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines